New Ibogaine Program Launches for Retired Athletes
A new partnership provides retired professional athletes access to clinical ibogaine treatment and support services.
Updated on Oct. 15, 2026 in Substance Abuse
Live Poll
Should psychedelic-assisted therapy be used to treat traumatic brain injuries in professional athletes?
Ambio Life Sciences and the nonprofit Athletes for Care have launched a partnership to provide professional athletes access to ibogaine treatment. The initiative aims to address the long-term impact of traumatic brain injuries among retired sports figures.
Why it matters
This partnership seeks to address the currently limited effective treatment options for traumatic brain injury in retired professional athletes. It connects former players with clinical programs while offering community-based support and integration coaching.
A 2024 Stanford University study of 30 U.S. Special Forces veterans showed significant symptom reduction following ibogaine treatment, including an 88% drop in PTSD and 87% in depression. These findings are preliminary and have not been replicated in controlled athlete cohorts.
The players
Ambio Life Sciences
A company that operates clinical facilities for ibogaine treatment in Mexico and Malta.
Athletes for Care
A nonprofit organization that provides peer support, community resources, and advocacy for professional athletes.
The details
The five-day Ambio Foundational Program involves a single ibogaine flood dose administered in clinical settings in Mexico or Malta. Athletes for Care provides peer counseling, wellness sessions, and spousal support, while the Casey Skudin 343 Fund offers preparation and integration coaching. The partnership reserves dedicated quarterly clinical space for these cohorts.
Timeline
September 2026: Five retired NHL and NFL athletes participated in the first treatment program in Baja California.
October 15, 2026: Ambio Life Sciences and Athletes for Care formally announced their partnership.
Health Landscape
This effort marks an attempt to translate promising data from veteran populations into the professional sports world. It follows a 2024 Stanford University study of ibogaine in veterans that established the current preliminary evidence base for symptom reduction.
The use of ibogaine remains a clinical and experimental approach that is not widely standardized for brain injury. Retired athletes experiencing persistent neurological or mental health symptoms should discuss all potential treatment avenues with their specialized medical team.
The takeaway
While preliminary data suggests ibogaine may reduce mental health symptoms in specific populations, it is not yet established as a standard treatment for retired athletes. Patients should prioritize conventional, evidence-backed care and discuss any alternative options with a qualified physician.
Further reading
For more information on current treatment trends, visit our Substance Abuse section.
More information
To learn more about support services, visit the Athletes for Care nonprofit homepage.
Source note: This article includes information reported by The Manila times.
Live Poll
Should psychedelic-assisted therapy be used to treat traumatic brain injuries in professional athletes?
